• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST段抬高型心肌梗死

ST elevation myocardial infarction.

作者信息

Choudhury Tawfiq, West Nick Ej, El-Omar Magdi

机构信息

Manchester Royal Infirmary, Manchester, UK.

Papworth Hospital, Cambridge, UK.

出版信息

Clin Med (Lond). 2016 Jun;16(3):277-82. doi: 10.7861/clinmedicine.16-3-277.

DOI:10.7861/clinmedicine.16-3-277
PMID:27251920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5922709/
Abstract

ST segment elevation myocardial infarction remains a significant contributor to morbidity and mortality worldwide, despite a declining incidence and better survival rates. It usually results from thrombotic occlusion of a coronary artery at the site of a ruptured or eroded plaque. Diagnosis is based on characteristic symptoms and electrocardiogram changes, and confirmed subsequently by raised cardiac enzymes. Prognosis is dependent on the size of the infarct, presence of collaterals and speed with which the occluded artery is reopened. Mechanical reperfusion by primary percutaneous coronary intervention is superior to fibrinolytic therapy if delivered by an experienced team in a timely fashion. Post-reperfusion care includes monitoring for complications, evaluation of left ventricular function, secondary preventive therapy and cardiac rehabilitation.

摘要

尽管ST段抬高型心肌梗死的发病率在下降且生存率有所提高,但它仍然是全球发病和死亡的重要原因。它通常是由破裂或糜烂斑块部位的冠状动脉血栓性闭塞引起的。诊断基于特征性症状和心电图变化,随后通过心肌酶升高得以证实。预后取决于梗死面积、侧支循环的存在以及闭塞动脉重新开通的速度。如果由经验丰富的团队及时进行,通过直接经皮冠状动脉介入治疗进行机械再灌注优于纤溶治疗。再灌注后护理包括监测并发症、评估左心室功能、二级预防治疗和心脏康复。

相似文献

1
ST elevation myocardial infarction.ST段抬高型心肌梗死
Clin Med (Lond). 2016 Jun;16(3):277-82. doi: 10.7861/clinmedicine.16-3-277.
2
Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).半剂量阿替普酶与直接经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死中的疗效和安全性:EARLY-MYO 试验(阿替普酶溶栓后早期常规冠状动脉造影与急性 ST 段抬高型心肌梗死直接经皮冠状动脉介入治疗的比较)。
Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27.
3
In the transition from fibrinolysis to primary PCI, the HERO trials help refine STEMI ECG interpretation and Q wave analysis potentially alters future management.在纤溶向直接经皮冠状动脉介入治疗(PCI)的转变过程中,HERO 试验有助于细化 ST 段抬高型心肌梗死(STEMI)心电图解读,而 Q 波分析可能改变未来的管理策略。
Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(1_suppl):26-33. doi: 10.1177/2048872618795513. Epub 2018 Aug 17.
4
Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.ST段抬高型心肌梗死患者药物介入策略与直接经皮冠状动脉介入治疗的倾向评分匹配分析
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003508.
5
Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.尼可地尔对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者梗死面积的影响:CHANGE 试验。
J Am Heart Assoc. 2022 Sep 20;11(18):e026232. doi: 10.1161/JAHA.122.026232. Epub 2022 Sep 8.
6
Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.接受直接经皮冠状动脉介入治疗并接受溶栓治疗的急性ST段抬高型心肌梗死患者再灌注期的细胞凋亡动力学。
J Pak Med Assoc. 2016 Jul;66(7):808-14.
7
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial.直接经皮冠状动脉介入治疗后完全 ST 段回落的临床影响及预测因素:ATLANTIC 试验的亚组分析。
Eur Heart J Acute Cardiovasc Care. 2019 Apr;8(3):208-217. doi: 10.1177/2048872617727722. Epub 2017 Aug 25.
8
Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.临床实践中 ST 段抬高型心肌梗死的药物侵入策略与直接经皮冠状动脉介入治疗的比较:来自 Vital Heart Response 注册研究的见解。
Circ Cardiovasc Interv. 2019 Oct;12(10):e008059. doi: 10.1161/CIRCINTERVENTIONS.119.008059. Epub 2019 Oct 14.
9
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.目前吸烟与急性 ST 段抬高型心肌梗死预后:新的病理生理学见解。
JACC Cardiovasc Imaging. 2019 Jun;12(6):993-1003. doi: 10.1016/j.jcmg.2018.05.022. Epub 2018 Jul 18.
10
ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死。
Nat Rev Dis Primers. 2019 Jun 6;5(1):39. doi: 10.1038/s41572-019-0090-3.

引用本文的文献

1
Identification of Biomarkers for Acute Myocardial Infarction Based on Cell Senescence Genes and Machine Learning.基于细胞衰老基因和机器学习的急性心肌梗死生物标志物识别
Anatol J Cardiol. 2025 Aug;29(8):409-422. doi: 10.14744/AnatolJCardiol.2025.5129.
2
Extended Hematological Parameters and Short-Term Mortality in Sepsis Patients: A Retrospective Study.脓毒症患者的扩展血液学参数与短期死亡率:一项回顾性研究
J Clin Med. 2025 May 7;14(9):3243. doi: 10.3390/jcm14093243.
3
Eosinophil percentage and platelet counts: Association with in-hospital mortality in ST-segment elevated myocardial infarction.嗜酸性粒细胞百分比与血小板计数:与ST段抬高型心肌梗死患者院内死亡率的关联
ARYA Atheroscler. 2024;20(6):34-42. doi: 10.48305/arya.2024.42494.2942.
4
Machine-learning based risk prediction of in-hospital outcomes following STEMI: the STEMI-ML score.基于机器学习的ST段抬高型心肌梗死住院结局风险预测:ST段抬高型心肌梗死机器学习评分
Front Cardiovasc Med. 2024 Oct 10;11:1454321. doi: 10.3389/fcvm.2024.1454321. eCollection 2024.
5
Growth differentiation factor-15 as a biomarker of coronary microvascular dysfunction in ST-segment elevation myocardial infarction.生长分化因子-15作为ST段抬高型心肌梗死中冠状动脉微血管功能障碍的生物标志物。
Heliyon. 2024 Jul 30;10(15):e35476. doi: 10.1016/j.heliyon.2024.e35476. eCollection 2024 Aug 15.
6
Echocardiographic Predictors of Improvement of Left Ventricular Ejection Fraction below 35% in Patients with ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死患者左心室射血分数低于35%时左心室射血分数改善的超声心动图预测指标
J Clin Med. 2024 Jul 9;13(14):4016. doi: 10.3390/jcm13144016.
7
Beyond Cardiology: A Rare Encounter With Small Bowel Obstruction Disguised as Inferior Wall ST-Elevation Myocardial Infarction.超越心脏病学:一次罕见的遭遇——伪装成下壁ST段抬高型心肌梗死的小肠梗阻
ACG Case Rep J. 2024 Jun 27;11(7):e01412. doi: 10.14309/crj.0000000000001412. eCollection 2024 Jul.
8
The COVID-19 impact on STEMI disparities.新型冠状病毒肺炎对 ST 段抬高型心肌梗死差异的影响。
Heliyon. 2024 May 31;10(11):e32218. doi: 10.1016/j.heliyon.2024.e32218. eCollection 2024 Jun 15.
9
Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction.代谢组学分析鉴定出差异代谢物作为急性心肌梗死的生物标志物。
Biomolecules. 2024 Apr 29;14(5):532. doi: 10.3390/biom14050532.
10
The Clinical and Economic Impact of Delayed Reperfusion Therapy: Real-World Evidence.延迟再灌注治疗的临床和经济影响:真实世界证据。
Arq Bras Cardiol. 2024 May 13;121(5):e20230650. doi: 10.36660/abc.20230650. eCollection 2024.

本文引用的文献

1
COOL AMI EU pilot trial: a multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction.COOL AMI EU 试验:一项多中心、前瞻性、随机对照试验,旨在评估在急性心肌梗死患者经皮介入治疗中应用冷却作为辅助治疗的效果。
EuroIntervention. 2017 Aug 4;13(5):e531-e539. doi: 10.4244/EIJ-D-17-00279.
2
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.ST段抬高型心肌梗死血栓抽吸术后的结局:前瞻性随机TOTAL试验的1年随访
Lancet. 2016 Jan 9;387(10014):127-35. doi: 10.1016/S0140-6736(15)00448-1. Epub 2015 Oct 22.
3
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.比伐卢定或普通肝素治疗急性冠脉综合征。
N Engl J Med. 2015 Sep 10;373(11):997-1009. doi: 10.1056/NEJMoa1507854. Epub 2015 Sep 1.
4
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).2015年欧洲心脏病学会(ESC)非持续性ST段抬高型急性冠脉综合征患者管理指南:欧洲心脏病学会(ESC)非持续性ST段抬高型急性冠脉综合征患者管理工作组
Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29.
5
Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction.TOTAL试验中的卒中:一项关于ST段抬高型心肌梗死常规血栓切除术与单纯经皮冠状动脉介入治疗的随机试验。
Eur Heart J. 2015 Sep 14;36(35):2364-72. doi: 10.1093/eurheartj/ehv296. Epub 2015 Jun 29.
6
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.药物洗脱支架经皮冠状动脉介入治疗后双重抗血小板治疗的最佳持续时间:随机对照试验的荟萃分析
BMJ. 2015 Apr 16;350:h1618. doi: 10.1136/bmj.h1618.
7
Complete versus culprit-only revascularization for ST-segment-elevation myocardial infarction and multivessel disease: a meta-analysis and trial sequential analysis of randomized trials.ST段抬高型心肌梗死合并多支血管病变时完全血运重建与仅罪犯血管血运重建的比较:一项随机试验的荟萃分析和序贯分析
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.114.002142.
8
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者中桡动脉与股动脉入路的随机多中心试验。
Lancet. 2015 Jun 20;385(9986):2465-76. doi: 10.1016/S0140-6736(15)60292-6. Epub 2015 Mar 16.
9
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.药物洗脱支架置入后短期与长期双联抗血小板治疗:一项个体患者数据的两两比较和网络荟萃分析。
J Am Coll Cardiol. 2015 Mar 24;65(11):1092-102. doi: 10.1016/j.jacc.2014.12.046.
10
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.比伐卢定与肝素联合或不联合替罗非班用于急性心肌梗死患者经皮冠状动脉介入治疗的 BRIGHT 随机临床试验。
JAMA. 2015 Apr 7;313(13):1336-46. doi: 10.1001/jama.2015.2323.